These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20214620)

  • 1. Cellular senescence in the development and treatment of cancer.
    Saretzki G
    Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
    Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
    Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
    Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
    Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence and cancer chemotherapy resistance.
    Gordon RR; Nelson PS
    Drug Resist Updat; 2012; 15(1-2):123-31. PubMed ID: 22365330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor senescence as a determinant of drug response in vivo.
    Roninson IB
    Drug Resist Updat; 2002 Oct; 5(5):204-8. PubMed ID: 12450785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer.
    Francica P; Nisa L; Aebersold DM; Langer R; Bladt F; Blaukat A; Stroka D; Martínez MR; Zimmer Y; Medová M
    Clin Cancer Res; 2016 Nov; 22(21):5322-5336. PubMed ID: 27185371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes and pathways involved in senescence bypass identified by functional genetic screens.
    Roupakia E; Markopoulos GS; Kolettas E
    Mech Ageing Dev; 2021 Mar; 194():111432. PubMed ID: 33422562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
    Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
    Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting genes in insulin-associated signalling pathway, DNA damage, cell proliferation and cell differentiation pathways by tocotrienol-rich fraction in preventing cellular senescence of human diploid fibroblasts.
    Durani LW; Jaafar F; Tan JK; Tajul Arifin K; Mohd Yusof YA; Wan Ngah WZ; Makpol S
    Clin Ter; 2015; 166(6):e365-73. PubMed ID: 26794818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase p38 and retinoblastoma protein signalling is required for DNA damage-mediated formation of senescence-associated heterochromatic foci in tumour cells.
    Zhang Y; Gao Y; Zhao L; Han L; Lu Y; Hou P; Shi X; Liu X; Tian B; Wang X; Huang B; Lu J
    FEBS J; 2013 Sep; 280(18):4625-39. PubMed ID: 23859194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cellular senescence in cancer therapy: is it true or not?
    Zhang Y; Yang JM
    Acta Pharmacol Sin; 2011 Oct; 32(10):1199-207. PubMed ID: 21909124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.
    Di Micco R; Sulli G; Dobreva M; Liontos M; Botrugno OA; Gargiulo G; dal Zuffo R; Matti V; d'Ario G; Montani E; Mercurio C; Hahn WC; Gorgoulis V; Minucci S; d'Adda di Fagagna F
    Nat Cell Biol; 2011 Mar; 13(3):292-302. PubMed ID: 21336312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated approach for monitoring cell senescence.
    Pospelova TV; Chitikova ZV; Pospelov VA
    Methods Mol Biol; 2013; 965():383-408. PubMed ID: 23296673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.
    Tonnessen-Murray CA; Lozano G; Jackson JG
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27881444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence in tumours: evidence from mice and humans.
    Collado M; Serrano M
    Nat Rev Cancer; 2010 Jan; 10(1):51-7. PubMed ID: 20029423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide metabolism, oncogene-induced senescence and cancer.
    Aird KM; Zhang R
    Cancer Lett; 2015 Jan; 356(2 Pt A):204-10. PubMed ID: 24486217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking senescence: context-dependent effects of SASP in cancer.
    Faget DV; Ren Q; Stewart SA
    Nat Rev Cancer; 2019 Aug; 19(8):439-453. PubMed ID: 31235879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.